Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/29/2013 | US8569256 Cationic lipids and methods for the delivery of therapeutic agents |
10/29/2013 | US8569255 Post-exposure therapy of influenza A infections |
10/29/2013 | US8569253 Methods and compositions for gene inactivation |
10/29/2013 | US8569252 Nucleolin specific aptamer and use thereof |
10/29/2013 | US8569227 Stabilized fibronectin domain compositions, methods and uses |
10/29/2013 | US8569225 Targeting complement factor H for treatment of diseases |
10/29/2013 | US8569066 Genetically engineered recombinant Escherichia coli producing L-tryptophan having originally L-phenylalanine productivity, and method for producing L-tryptophan using the microorganism |
10/29/2013 | US8569065 Compositions and methods for the delivery of biologically active RNAs |
10/29/2013 | US8569064 Manipulation of flavonoid biosynthesis in plants |
10/29/2013 | US8569054 Mammalian cell lines for increasing longevity and protein yield from a cell culture |
10/29/2013 | US8569051 Expression vector for gene therapy |
10/29/2013 | US8569041 Multiplex automated genome engineering |
10/29/2013 | US8569039 Ethanol resistance Saccharomyces cerevisiae GP-01 by protoplast fusion, method for manufacturing thereof, method for manufacturing yeast containing high content of bio organic germanium by using Saccharomyces cerevisiae GP-01 and high water soluble sodium metagermanate as a germanium source |
10/29/2013 | US8569038 Transformant having an increased frequency of homologous recombination |
10/29/2013 | US8569035 Subtilase variants |
10/29/2013 | US8569033 Surfactant tolerant cellulase and method for modification thereof |
10/29/2013 | US8569030 Type II restriction-modification system methylation subunit of Alicyclobacillus acidocaldarius |
10/29/2013 | US8569025 Terpene synthases from santalum |
10/29/2013 | US8569021 Materials and methods for the production of biodiesel |
10/29/2013 | US8569017 Method for the preventing and/or treating IL-1 beta lung pathology in mammals by administering a uric acid reducing compound |
10/29/2013 | US8569015 RPA optimization |
10/29/2013 | US8569013 Penicillin-G acylases |
10/29/2013 | US8568990 Methods for identifying compounds that modulate sensory signaling through the taste cell specific G-protein coupled receptor GPCR-B4 |
10/29/2013 | US8568972 Substances causing differentiation |
10/29/2013 | US8568971 Methods and compositions involving microRNA |
10/29/2013 | US8568742 Methods and compositions involving immunostimulatory oligodeoxynucleotides |
10/29/2013 | US8568733 HER-2/neu fusion proteins |
10/29/2013 | US8568731 Staphylococcus aureus antigenic polypeptides and compositions |
10/29/2013 | US8568709 Thymidylate kinase fusions and uses thereof |
10/29/2013 | US8568707 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
10/29/2013 | US8568706 Modified human interferon-beta polypeptides |
10/29/2013 | CA2612362C Cdna construct of salmonidae alphavirus |
10/29/2013 | CA2589204C Recombinant bcg strains with enhanced ability to escape the endosome |
10/29/2013 | CA2580504C Enhanced antisense oligonucleotides |
10/29/2013 | CA2546619C Il-23 and its receptor; related reagents and methods |
10/29/2013 | CA2542787C Method and kit for primer based multiplex amplification of nucleic acids |
10/29/2013 | CA2542053C Dna cloning vector plasmids and methods for their use |
10/29/2013 | CA2535515C Cd20-binding polypeptide compositions |
10/29/2013 | CA2514450C Glyphosate tolerant alfalfa events and methods for detection thereof |
10/29/2013 | CA2509136C Human il-1 beta antagonists |
10/29/2013 | CA2485939C Inducible eukaryotic expression system |
10/29/2013 | CA2483006C Methods of creating modified promoters resulting in varying levels of gene expression |
10/29/2013 | CA2477406C Dna vaccine against proliferating endothelial cells and methods of use thereof |
10/29/2013 | CA2468772C System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations |
10/29/2013 | CA2466128C Antibodies to cd40 |
10/29/2013 | CA2453100C Novel human hepatoma lines, methods for obtaining same and uses thereof |
10/29/2013 | CA2446408C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
10/29/2013 | CA2442363C Reducing the immunogenicity of fusion proteins |
10/29/2013 | CA2435672C Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
10/29/2013 | CA2396992C Hybrid cells |
10/29/2013 | CA2382120C Single-stranded oligodeoxynucleotide mutational vectors |
10/29/2013 | CA2375467C Antisense therapy for hormone-regulated tumors |
10/29/2013 | CA2371794C Human antibiotic proteins |
10/29/2013 | CA2316080C Sex-specific insemination of mammals with low number of sperm cells |
10/29/2013 | CA2295920C Oligonucleotide reverse transcription primers for efficient detection of hiv-1 and hiv-2 and methods of use thereof |
10/26/2013 | CA2782039A1 Plants and seeds of spring canola variety scv942568 |
10/26/2013 | CA2782038A1 Plants and seeds of spring canola variety scv967592 |
10/26/2013 | CA2781490A1 Plants and seeds of spring canola variety scv318181 |
10/26/2013 | CA2781488A1 Plants and seeds of spring canola variety scv259778 |
10/24/2013 | WO2013159103A1 Programming and reprogramming of cells |
10/24/2013 | WO2013159091A2 Mirna modulators of thermogenesis |
10/24/2013 | WO2013159085A1 Compositions and methods for identifying and diagnosing salt sensitivity of blood pressure |
10/24/2013 | WO2013159036A1 Adeno associated virus plasmids and vectors |
10/24/2013 | WO2013159005A2 A method of improving the activity of cellulase enzyme mixtures in the saccharification of (ligno)cellulosic material |
10/24/2013 | WO2013158984A1 Biomarkers to identify patients that will respond to treatment and treating such patients |
10/24/2013 | WO2013158966A1 Bronze bug control agents |
10/24/2013 | WO2013158962A1 Imaging-aided gene therapy using mesenchymal stem cells as target-delivery vehicle |
10/24/2013 | WO2013158890A1 Generation of induced pluripotent stem cells by modulation of δnp63 or dcgr8 |
10/24/2013 | WO2013158879A1 Composition and methods for highly efficient gene transfer using aav capsid variants |
10/24/2013 | WO2013158868A1 Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation |
10/24/2013 | WO2013158860A1 Devices and methods for nucleic acid preparation and analysis |
10/24/2013 | WO2013158819A2 Method for generation of conditionally immortalized hematopoietic progenitor cell lines with multiple lineage potential |
10/24/2013 | WO2013158766A1 Synthetic brassica-derived chloroplast transit peptides |
10/24/2013 | WO2013158674A1 Detection of extracellular jcv micrornas |
10/24/2013 | WO2013158664A2 Use of engineered viruses to specifically kill senescent cells |
10/24/2013 | WO2013158309A2 Non-disruptive gene targeting |
10/24/2013 | WO2013158292A1 Hla class ii deficient cells, hla class i deficient cells capable of expressing hla class ii proteins, and uses thereof |
10/24/2013 | WO2013158274A1 ANTI-MIGE ANTIBODIES THAT BIND TO THE JUNCTION BETWEEN CH4 AND CεMX DOMAINS |
10/24/2013 | WO2013158268A1 Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof |
10/24/2013 | WO2013158263A1 Replication-competent vesicular stomatitis viruses |
10/24/2013 | WO2013158228A1 Transgenic plants with enhanced traits |
10/24/2013 | WO2013158227A1 Transgenic plants with enhanced traits |
10/24/2013 | WO2013158061A1 Recombinant mycobacterium encoding a heparin-binding hemagglutinin (hbha) fusion protein and uses thereof |
10/24/2013 | WO2013158046A1 Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies |
10/24/2013 | WO2013158032A1 Methods for increasing cotton fiber length |
10/24/2013 | WO2013157887A1 Recombinant microorganism having kaurene, kaurenoic acid or steviol producing ability, and method for preparing kaurene, kaurenoic acid or steviol using same |
10/24/2013 | WO2013157821A1 Detection of target nucleic acid sequence by pto cleavage and extension-dependent signaling oligonucleotide cleavage |
10/24/2013 | WO2013157667A1 Dna analysis micro-channel chip |
10/24/2013 | WO2013157666A1 Dna analysis micro-channel chip |
10/24/2013 | WO2013157625A1 Method and kit for detecting hla-a*24:02 |
10/24/2013 | WO2013157580A1 Method for providing plants with environmental stress resistance |
10/24/2013 | WO2013157502A1 Novel campanula flavonoid 3',5'-hydroxylase gene and use of same |
10/24/2013 | WO2013157215A1 Method for assessing endometrial cancer susceptibility |
10/24/2013 | WO2013157105A1 Mucin 5ac specific human antibody and use thereof |
10/24/2013 | WO2013157102A1 Mucin 5ac specific human antibody and use thereof |
10/24/2013 | WO2013157010A1 Methods and compositions for rnai-based cancer treatment |
10/24/2013 | WO2013156989A1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids |
10/24/2013 | WO2013156920A1 Klotho variant polypeptides and uses thereof in therapy |
10/24/2013 | WO2013156625A1 Tfeb gene therapy of alpha-1-antitrypsin deficiency |
10/24/2013 | WO2013156566A1 Thrips resistant cabbage |